Grail, the liquid biopsy startup, shows 'impressive,' if early, results

Grail, the liquid biopsy startup, shows 'impressive,' if early, results

STAT Plus: Grail, a deep-pocketed startup, shows ‘impressive,’ if early, results for cancer blood test

By MATTHEW HERPER

ADOBE

The Menlo Park, Calif.-based company, has raised $1.6 billion in venture capital to prove a blood test detect cancer in healthy people.

READ MORE